The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 0.00 (0.00%)
Spread: 4.50 (1.382%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 328.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps

Tue, 21st Sep 2021 09:14

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Kingfisher top FTSE 100 loser despite positive results

* Royal Dutch Shell sells U.S. oilfield assets

* Stagecoast surges on merger talks with rival

* FTSE 100 up 1.0%, FTSE 250 adds 0.8%
(Updates to close)

By Shashank Nayar

Sept 21 (Reuters) - London's FTSE 100 rebounded on Tuesday,
aided by gains in energy and healthcare stocks, and Entain
jumped to the top of the index after the Ladbrokes owner said it
received an offer from DraftKings.

The blue-chip FTSE 100 ended 1.0% higher and
recorded its best session in two months. Oil major BP and
Royal Dutch Shell were among the top boosts.

Entain jumped 18.0%, leading gains on travel and
leisure stocks, after it confirmed that U.S.
fantasy sports betting company DraftKings has made an
offer to buy the British gambling firm in a deal that one media
report said could be valued at $20 billion.

The FTSE 100 has gained 8% so far this year on support from
dovish central bank policies and re-opening optimism. However,
higher inflation pressures have raised scepticism among
investors that central banks might hint later this week towards
pulling back massive asset purchases sooner than expected.

"Investors are still progressing ahead with fingers crossed
as the Fed and the BoE are unlikely to declare any tapering
measures this time, as it would potentially unsettle the global
equity environment before the third-quarter earnings season,"
said Kunal Sawhney, chief executive at Kalkine.

Healthcare stocks gained 1.5% with drugmakers
including AstraZeneca, Indivior, Oxford
BioMedica up between 1.6% and 4.8%.

The domestically focussed mid-cap index rose 0.8%,
with travel stocks being among the top gainers.

In earnings-driven moves, Kingfisher fell 4.9% to
the bottom of the FTSE 100 even as the British home improvement
retailer reported a jump in first-half profit.

Royal Dutch Shell jumped 3.6% after it said it would sell
its Permian Basin assets to ConocoPhillips for $9.5
billion in cash, exiting the largest U.S. oilfield.

British transport company Stagecoach Group surged
27.0% to the top of mid-cap index, after it said it was in talks
with rival operator National Express about a possible
all-share merger. National Express was up 7.6%.

Semiconductor technology company Alphawave jumped
19.4% on raising its 2021 guidance after reporting a 140% rise
in first-half revenue.
(Reporting by Shashank Nayar and Amal S in Bengaluru; Editing
by Saumyadeb Chakrabarty, Subhranshu Sahu and Marguerita Choy)

More News
22 Apr 2022 12:01

DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:

Read more
22 Apr 2022 09:21

LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

Read more
20 Apr 2022 17:11

LONDON MARKET CLOSE: Stocks up as G20 finance heads meet; Netflix down

(Alliance News) - Stocks in London ended higher on Wednesday as investors continued to track the war in Ukraine, while in the US, Netflix weighed on the tech-heavy Nasdaq index.

Read more
20 Apr 2022 12:11

LONDON MARKET MIDDAY: Europe pushes higher as Netflix shockwave wanes

(Alliance News) - The FTSE 100 index moved upwards with a bit more conviction as the morning progressed in London on Wednesday, shaking off a mixed US earnings season.

Read more
20 Apr 2022 10:00

Oxford BioMedica shares fall as warns on 2022 amid Covid jab pause

(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause.

Read more
20 Apr 2022 09:10

Oxford Biomedica reports year of solid growth

(Sharecast News) - Oxford Biomedica reported a 63% improvement in total revenues in its preliminary results on Wednesday, to £142.8m, although its outlook was somewhat less rosy amid a pause in vaccine manufacturing.

Read more
13 Apr 2022 16:05

UK earnings, trading statements calendar - next 7 days

Thursday 14 April 
Ashmore Group PLCTrading Statement
Dunelm Group PLCTrading Statement
Hays PLCTrading Statement
Mediclinic International PLCTrading Statement
Ninety One PLC and LtdTrading Statement
Norcros PLCTrading Statement
Friday 15 April 
no events scheduled 
Monday 18 April 
no events scheduled 
Tuesday 19 April  
JTC PLCFull Year Results
Kainos Group PLCTrading Statement
Rio Tinto PLCQ1 Production Results
Wednesday 20 April  
Bunzl PLCTrading Statement
Carr's Group PLCHalf Year Results
Centamin PLCTrading Statement
Hunting PLCTrading Statement
IntegraFin Holdings PLCTrading Statement
John Wood Group PLCFull Year Results
Oxford Biomedica PLCFull Year Results
Petra Diamonds LtdTrading Statement
Quilter PLCTrading Statement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Feb 2022 09:37

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree

Read more
1 Feb 2022 08:51

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies

Read more
1 Feb 2022 07:40

Oxford Biomedica's Parkinson's licensee pulls out

(Sharecast News) - Oxford Biomedica's licensee for a Parkinson's disease treatment has pulled out of development and returned the rights to the UK company.

Read more
28 Jan 2022 19:17

UPDATE: Oxford BioMedica raises GBP80 million via placing

UPDATE: Oxford BioMedica raises GBP80 million via placing

Read more
28 Jan 2022 16:59

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

LONDON MARKET CLOSE: Stocks close out rollercoaster week with losses

Read more
28 Jan 2022 16:19

CORRECT: Oxford BioMedica to acquire 80% ownership of new US business

CORRECT: Oxford BioMedica to acquire 80% ownership of new US business

Read more
28 Jan 2022 12:13

LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed

LONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed

Read more
28 Jan 2022 10:27

Oxford BioMedica to acquire 80% ownership of new US virus business

Oxford BioMedica to acquire 80% ownership of new US virus business

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.